Maxwell S. Krieger

Maxwell S. Krieger

Auto-generated profile, based on publicly available information

Maxwell S. Krieger

Affiliation Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, United States of America

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MKMaxwell S. Krieger
Maxwell S. Krieger
WGWilliam Goedel
William Goedel
JBJane A. Buxton
Jane A. Buxton
MLMark Lysyshyn
Mark Lysyshyn
EBEdward Bernstein
Edward Bernstein
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall

8 January 2019 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
JGJacqueline E. Goldman
Jacqueline E. Goldman
KWKatherine M. Waye
Katherine M. Waye
KPKobe A. Periera
Kobe A. Periera
MKMaxwell S. Krieger
Maxwell S. Krieger
JYJesse L. Yedinak
Jesse L. Yedinak
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
In 2016, drug overdose deaths exceeded 64,000 in the United States, driven by a sixfold increase in deaths attributable to illicitly manufactured fentanyl. Rapid fentanyl test strips (FTS), used to detect fentanyl in illicit drugs, may help inform people who use drugs about their risk of fentanyl exposure prior to consumption. This qualitative study assessed perceptions of FTS among young adults. From May to September 2017, we recruited a convenience sample of 93 young adults in Rhode Island (age 18–35 years) with self-reported drug use in the past 30 days to participate in a pilot study aimed at better understanding perspectives of using take-home FTS for personal use. Participants completed a baseline quantitative survey, then completed a training to learn how to use the FTS. Participants then received ten FTS for personal use and were asked to return 2–4 weeks later to complete a brief quantitative and structured qualitative interview. Interviews were transcribed, coded, and double coded in NVivo (Version 11). Of the 81 (87%) participants who returned for follow-up, the majority (n = 62, 77%) used at least one FTS, and of those, a majority found them to be useful and straightforward to use. Positive FTS results led some participants to alter their drug use behaviors, including discarding their drug supply, using with someone else, and keeping naloxone nearby. Participants also reported giving FTS to friends who they felt were at high risk for fentanyl exposure. These findings provide important perspectives on the use of FTS among young adults who use drugs. Given the high level of acceptability and behavioral changes reported by study participants, FTS may be a useful harm reduction intervention to reduce fentanyl overdose risk among this population. The study protocol is registered with the US National Library of Medicine, Identifier NCT03373825, 12/24/2017, registered retrospectively. https://clinicaltrials.gov/ct2/show/NCT03373825?id=NCT03373825&rank=1

1 June 2018 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
SHScott E. Hadland
Scott E. Hadland
MCMagdalena Cerdá
Magdalena Cerdá
YLYu Li
Yu Li
MKMaxwell S. Krieger
Maxwell S. Krieger
BMBrandon D. L. Marshall
Brandon D. L. Marshall
Despite the increasing contribution of heroin and illicitly manufactured fentanyl to opioid-related overdose deaths in the United States, 40% of deaths involve prescription opioids.1 Prescription opioids are commonly the first opioid encountered in a trajectory toward illicit consumption.2 Although opioid prescribing has declined nationally, rates in 2015 were triple those in 1999 and remain elevated in regions of the country with higher numbers of overdoses.3

8 February 2018 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
MKMaxwell S. Krieger
Maxwell S. Krieger
JYJesse L. Yedinak
Jesse L. Yedinak
JBJane A. Buxton
Jane A. Buxton
MLMark Lysyshyn
Mark Lysyshyn
EBEdward Bernstein
Edward Bernstein
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
Synthetic opioid overdose mortality among young adults has risen more than 300% in the USA since 2013, primarily due to the contamination of heroin and other drugs with illicitly manufactured fentanyl. Rapid test strips, which can be used to detect the presence of fentanyl in drug samples (before use) or urine (after use), may help inform people about their exposure risk. The purpose of this study was to determine whether young adults who use drugs were willing to use rapid test strips as a harm reduction intervention to prevent overdose. We hypothesized that those who had ever overdosed would be more willing to use the test strips. We recruited a convenience sample of young adults who use drugs in Rhode Island from May to September 2017. Eligible participants (aged 18 to 35 with past 30-day drug use) completed an interviewer-administered survey. The survey assessed participant’s socio-demographic and behavioral characteristics, overdose risk, as well as suspected fentanyl exposure, and willingness to use take-home rapid test strips to detect fentanyl contamination in drugs or urine. Participants were then trained to use the test strips and were given ten to take home. Among 93 eligible participants, the mean age was 27 years (SD = 4.8), 56% (n = 52) of participants were male, and 56% (n = 52) were white. Over one third (n = 34, 37%) had a prior overdose. The vast majority (n = 86, 92%) of participants wanted to know if there was fentanyl in their drug supply prior to their use. Sixty-five (70%) participants reported concern that their drugs were contaminated with fentanyl. After the brief training, nearly all participants (n = 88, 95%) reported that they planned to use the test strips. More than 90% of participants reported willingness to use rapid test strips regardless of having ever overdosed, suggesting that rapid fentanyl testing is an acceptable harm reduction intervention among young people who use drugs in Rhode Island. Study follow-up is ongoing to determine whether, how, and under what circumstances participants used the rapid test strips and if a positive result contributed to changes in overdose risk behavior.

1 November 2018 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
ESElizabeth A. Samuels
Elizabeth A. Samuels
SBSteven L. Bernstein
Steven L. Bernstein
BMBrandon D.L. Marshall
Brandon D.L. Marshall
MKMaxwell Krieger
Maxwell Krieger
JBJanette Baird
Janette Baird
MMMichael J. Mello
Michael J. Mello

1 August 2017 in International Journal of Drug Policy
Verified
Journal Article
Closed access
BMBrandon David Lewis Marshall
Brandon David Lewis Marshall
MKMaxwell S. Krieger
Maxwell S. Krieger
JYJesse L. Yedinak
Jesse L. Yedinak
POPatricia Ogera
Patricia Ogera
PBPriya Banerjee
Priya Banerjee
TGTraci C. Green
Traci C. Green